HFS
KRYS icon

Hughes Financial Services’s Krystal Biotech KRYS Stock Holding History

Hughes Financial Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29K Buy
5
+1
+25% +$266 ﹤0.01% 700
2025
Q4 		$986 Hold
4
– – ﹤0.01% 718
2025
Q3 		$798 Hold
4
– – ﹤0.01% 778
2025
Q2 		$544 Buy
+4
New +$588 ﹤0.01% 922

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hughes Financial Services's KRYS Position: Q1 2026 in Review

Hughes Financial Services increased its Krystal Biotech (KRYS) stake by 25% in Q1 2026, buying an estimated $266 and bringing the position to 5 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Hughes Financial Services first reported a position in KRYS in Q2 2025 and has held it in 4 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Hughes Financial Services held 5 shares of Krystal Biotech worth $1.29K as of Q1 2026.
  • Hughes Financial Services bought 1 Krystal Biotech share in Q1 2026, an estimated $266.
  • Krystal Biotech made up ﹤0.01% of Hughes Financial Services's portfolio in Q1 2026, its #700 holding.
  • Hughes Financial Services first reported a position in Krystal Biotech in Q2 2025 and has held it in 4 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Hughes Financial Services's 13F filing for Q1 2026, filed 29 Apr 2026.